A double-blind, placebo-controlled study utilised intravenous allogeneic human MSCs in fifty three article-MI individuals, with identical adverse events concerning both groups. Ambulatory EKG showed diminished episodes of ventricular tachycardia, and also enhanced pressured expiratory volume in a single second on pulmonary functionality testing fro